The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

BACKGROUND: Data from 12-week placebo-controlled trials have led to mounting concerns about increased mortality in patients with Alzheimer's disease (AD) who are prescribed antipsychotics; however, there are no mortality data from long-term placebo-controlled trials. We aimed to assess whether...

Full description

Bibliographic Details
Main Authors:	Ballard, C, Hanney, M, Theodoulou, M, Douglas, S, Mcshane, R, Kossakowski, K, Gill, R, Juszczak, E, Yu, L, Jacoby, R
Format:	Journal article
Language:	English
Published:	2009

Similar Items

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
by: Ballard, C, et al.
Published: (2008)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
by: Ballard, C, et al.
Published: (2008)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
by: Ballard, C, et al.
Published: (2008)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
by: Clive Ballard, et al.
Published: (2008-04-01)

Antipsychotics withdrawal in adults with intellectual disability and challenging behaviour: study protocol for a multicentre double-blind placebo-controlled randomised trial
by: Sylvie Beumer, et al.
Published: (2021-09-01)

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
by: Hanney, M, et al.
Published: (2012)

Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
by: Chris Fox, et al.
Published: (2012-01-01)

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
by: Ballard, C, et al.
Published: (2005)

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD).
by: Ballard, C, et al.
Published: (2015)

A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms.
by: Ussher, M, et al.
Published: (2011)

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
by: Derry, S, et al.
Published: (2007)

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.
by: Ballard, C, et al.
Published: (2004)

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe.
by: Fleischhacker, W, et al.
Published: (2002)

The microbiome of infants recruited to a randomised placebo-controlled probiotic trial (PiPS Trial)
by: Millar, M, et al.
Published: (2017)

The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial)
by: Michael Millar, et al.
Published: (2017-06-01)

Ethical considerations in placebo-controlled randomised clinical trials
by: Kenneth R. Kaufman
Published: (2015-06-01)

Dependence and withdrawal symptoms among waterpipe tobacco smokers enrolled in a double-blind, placebo-controlled, randomised trial
by: Mona Kanaan, et al.
Published: (2018-03-01)

Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial
by: Helge Haarmann, et al.
Published: (2016-08-01)

A blinded randomised placebo-controlled trial investigating the efficacy of morphine analgesia for procedural pain in infants: Trial protocol
by: Slater, R, et al.
Published: (2016)

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
by: S Banerjee, et al.
Published: (2013-02-01)

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
by: Leucht, S, et al.
Published: (2018)

Large Sample Size Fallacy in Trials About Antipsychotics for Neuropsychiatric Symptoms in Dementia
by: Tessa A. Hulshof, et al.
Published: (2020-02-01)

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
by: Ballard, C, et al.
Published: (2009)

Randomised controlled trials for informing perinatal care
by: Juszczak, E
Published: (2019)

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
by: Ratcliffe, P, et al.
Published: (1996)

Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
by: Chappell, L, et al.
Published: (2019)

The importance of using placebo controls in nonpharmacological randomised trials
by: Wartolowska, KA, et al.
Published: (2022)

Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial
by: Lamb, S, et al.
Published: (2018)

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration
by: Wardle, J, et al.
Published: (1996)

Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
by: Griffiths, J, et al.
Published: (2019)

Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.
by: Xianbin Li, et al.
Published: (2013-01-01)

Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care
by: Rhona Eveleigh, et al.
Published: (2017-11-01)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
by: G. Raghuthaman, et al.
Published: (2015-10-01)

Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial
by: Hartley, C, et al.
Published: (2018)

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial
by: Howard, R, et al.
Published: (2018)

Quality of life and paracetamol in advanced dementia (Q-PID): protocol of a randomised double-blind placebo-controlled crossover trial
by: Paulien H. van Dam, et al.
Published: (2018-11-01)

The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial
by: Cheah, P, et al.
Published: (2018)

Randomised controlled trials may underestimate drug effects: balanced placebo trial design.
by: Karen Lund, et al.
Published: (2014-01-01)

SUcceSS, SUrgery for Spinal Stenosis: protocol of a randomised, placebo-controlled trial
by: Anderson, D, et al.
Published: (2019)

Randomised placebo-controlled trials of surgery – ethical analysis and guidelines
by: Savulescu, J, et al.
Published: (2016)